Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, octobre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Fresenius Medical Care AG
FMS
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$22.16
0.03
0.14%
Dern. MÀJ: Oct 16, 3:59 PM
$22.28
0.15
0.68%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Options
Rapport sur les stocks
Privacy Manager
Fresenius Medical Care Financials
Fresenius Medical Care (FMS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B Est
Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.940 billion estimate.
Benzinga Newsdesk
PRO
Fresenius Medical Care Q2 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $5.651B Miss $5.720B Estimate
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. This is a 26.92 percent increase over earnings of $0.52 per share from
Benzinga Newsdesk
Earnings Scheduled For May 5, 2026
Benzinga Insights
PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.870B Est
Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.870 billion estimate.
Benzinga Newsdesk
PRO
Fresenius Medical Care Q1 Adj. EPS $0.53 Misses $0.59 Estimate, Sales $5.401B Miss $5.720B Estimate
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.59 by 10.17 percent. This is a 20.45 percent increase over earnings of $0.44 per share
Benzinga Newsdesk
PRO
Fresenius Medical Care Sees FY2026 Sales $23.764B vs $22.640B Est
Fresenius Medical Care (NYSE:FMS) sees FY2026 sales of $23.764 billion vs $22.640 billion analyst estimate.
Benzinga Newsdesk
